BL
GBT

Bleichroeder LP’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bleichroeder LP’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-125,000
Closed -$3.66M – 120
2021
Q4 		$3.66M Hold
125,000
– – 0.57% 30
2021
Q3 		$3.19M Buy
125,000
+25,000
+25% +$735K 0.52% 34
2021
Q2 		$3.5M Hold
100,000
– – 0.53% 36
2021
Q1 		$4.08M Buy
+100,000
New +$4.6M 0.69% 30

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bleichroeder LP's GBT Position: Q1 2022 in Review

Bleichroeder LP sold out of Global Blood Therapeutics, Inc. (GBT) in Q1 2022, closing a stake of 125,000 shares — an estimated $3.66M sold.

Bleichroeder LP first reported a position in GBT in Q1 2021 and held it in 4 quarters. The position peaked at $4.08M in Q1 2021. 204 funds tracked by Wall St. Rank hold GBT as of Q1 2022.

  • Bleichroeder LP reported no remaining Global Blood Therapeutics, Inc. position as of Q1 2022 after selling out during the quarter.
  • Bleichroeder LP sold 125,000 Global Blood Therapeutics, Inc. shares in Q1 2022, an estimated $3.66M.
  • Bleichroeder LP first reported a position in Global Blood Therapeutics, Inc. in Q1 2021 and held it in 4 quarters.
  • Bleichroeder LP's Global Blood Therapeutics, Inc. position peaked at $4.08M in Q1 2021.
  • 204 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q1 2022.

Based on Bleichroeder LP's 13F filing for Q1 2022, filed 11 May 2022.